Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Astellas’ Xospata wins AML approval, with Daiichi close behind

fiercepharmaDecember 05, 2018

Tag: AML , FDA , Novartis

PharmaSources Customer Service